Patents
Patents for C07D 211 - Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings (37,939)
06/2010
06/23/2010EP1594859B1 Indazolamides with analgesic activity
06/23/2010CN1835751B Therapeutic agents useful for treating pain
06/23/2010CN1823042B Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines
06/23/2010CN101754947A Process for preparation of sulfamide derivatives
06/23/2010CN101747259A Azasugars compounds, synthesis method and applications thereof
06/23/2010CN101161645B Urea derivatives as well as preparation method and uses thereof
06/22/2010US7741371 antiandrogens useful for suppressing spermatogenesis, treating hormone related conditions and prostate cancer; hormone inhibitors
06/22/2010US7741352 for the treatment or alleviation of pain, headaches, nervous system disorders or trauma, stroke, neurodegenerative diseases, cardiovascular disorders, inflammatory diseases, vision defects, hearing disorders, respiratory system disordres and urinary incontinence
06/22/2010US7741340 Hydroxy piperidine derivatives to treat gaucher disease
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2441398C Lipid lowering biphenylcarboxamides
06/22/2010CA2420996C Substituted heterocyclic compounds for treating multidrug resistance
06/17/2010WO2010066780A1 Spiroheterocyclic n-oxypiperidines as pesticides
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010US20100152454 Preparation of (n-heterocyclyl) aryl ethers
06/17/2010US20100152452 Stereoselective synthesis of piperidine derivatives
06/17/2010US20100152439 Production method
06/17/2010US20100152308 Novel aromatic compound and polyarylene copolymer having nitrogen-containing heterocycle including sulfonic acid group in side chain
06/17/2010US20100152253 Non-steroidal brassinosteroid mimetic
06/17/2010US20100152240 Pyrroline-2-one derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof
06/17/2010US20100152238 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
06/17/2010US20100152220 Indene derivatives as pharmaceutical agents
06/17/2010US20100152168 Substituted benzimidazolone derivatives, medicaments comprising them and their use
06/17/2010US20100152138 Cyclic amine bace-1 inhibitors having a benzamide substituent
06/17/2010US20100152098 Polybasic bacterial efflux pump inhibitors and therapeutic uses thereof
06/17/2010US20100151388 (Meth)acrylate compound, photosensitive polymer, and resist composition including the same
06/17/2010US20100150995 Process for the production of high-purity 2,4'-dimethyl-3-piperidino-propiophenone (tolperisone), pharmaceutical compositions that contain the latter, as well as active ingredient formulations that contain tolperisone
06/17/2010CA2748691A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010CA2746394A1 Spiroheterocyclic n-oxypiperidines as pesticides
06/16/2010EP2195294A1 Novel preparation process
06/16/2010EP2195293A2 Cycloptopyl amide derivatives
06/16/2010EP1436281B1 Piperidine- and piperazineacetamides as 17beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/16/2010CN1910145B Pyrrolidine derivatives acting as CCR3-receptor antagonists
06/16/2010CN1805944B Cyclic hydroxylamine as psychoactive compounds
06/16/2010CN1787996B Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
06/16/2010CN101743007A Inhibitors of akt/pkb with anti-tumor activity
06/16/2010CN101743002A New method for preparing isofagomine and its derivatives
06/15/2010US7737135 (2S)-2-[[4'-(methylsulfonyl)-3',5-bis(trifluoromethyl)[1,1'-biphenyl]-2-yl]oxy]-propanoic acid for example; asthma or rhinitis; orphan receptor CRTH2 modulators, prostaglandin D2 is a ligand of CRTH2
06/15/2010US7736396 Hair dyeing composition
06/15/2010CA2521647C Novel hydroxamates as therapeutic agents
06/15/2010CA2430518C Guanidine and amidine derivatives as factor xa inhibitors
06/10/2010WO2010065801A1 Amine substituted piperazine melanocortin receptor-specific compounds
06/10/2010WO2010065800A1 Hydrazine substituted piperidine melanocortin receptor-specific compounds
06/10/2010WO2010064631A1 Photobase generator
06/10/2010WO2010063802A1 3, 4-di-substituted cyclobutene- 1, 2 -diones as cxcr2 receptor antagonists
06/10/2010WO2010063774A1 Novel 4-(azacycloalkyl)benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/10/2010WO2010063670A1 Spiroheterocyclic n-oxyamides as pesticides
06/10/2010US20100145057 Novel prodrugs
06/10/2010US20100145003 Catalytic Deamination for Caprolactam Production
06/10/2010US20100144788 4- [2- (4-methylphenylsulfanyd-phenyl] piperidine with combined serotonin and norepinephrine reuptake inhibition for the treatment of adhd, melancholia, treatment resistent depression or residual symptoms in depression
06/10/2010US20100144720 Inhibitors of human tumor-expressed ccxckr2
06/10/2010US20100144708 Heterocyclic compounds containing nitrogen atoms or pharmaceutically acceptable salts thereof, process for the preparation thereof and pharmaceutical composition comprising the same for treatment of cancer
06/10/2010US20100144697 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144696 Stabilized pharmaceutical compositions containing a calcium channel blocker
06/10/2010US20100144681 Compounds for the treatment of alzheimer's disease
06/10/2010US20100144657 PHENYLPIPERIDINE MODULATORS OF mu-OPIOID RECEPTORS
06/10/2010US20100143505 Indanone inhibitors of acetylcholinesterase
06/10/2010CA2744711A1 Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases
06/10/2010CA2744128A1 Spiroheterocyclic n-oxyamides as pesticides
06/10/2010CA2742709A1 Novel 4- (azacycloalkyl) benzene-1,3-diol compounds as tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and in cosmetics
06/09/2010EP2194053A1 Stereoisomeric compounds and methods for the treatment of gastrointestinal and central nervous system disorders
06/09/2010EP2049508B1 N-hydroxy-3-(4-{3-phenyl-3-oxo-propenyl}-phenyl)-acrylamide derivatives and related compounds as histone deacetylase inhibitors for the treatment of cancer
06/09/2010EP1497273B1 Hydroxamic acid derivatives
06/09/2010CN1914152B New compounds, methods for their preparation and use thereof
06/09/2010CN1805935B Piperidinium and pyrrolidinium derivatives as ligands for the muscarinic M3 receptor
06/09/2010CN1696115B Synthesized building block of derivative of 4-substituent-4-amido-piperidine, preparation method and application
06/09/2010CN101730683A Indane-amine derivatives, their preparation and use as medicaments
06/09/2010CN101730682A Novel 4-{3-[4-(3-{4-[amino(butoxycarbonylimino)methyl]phenoxy}propyl)-1-piperidinyl]propoxy]-n'-(butoxycarbonyl)benzamidine crystals
06/09/2010CN101723935A 1,5-diaryl-substituted 2,4-dienone derivative as well as preparation method and application thereof
06/09/2010CN101723880A 1-phenyl-4-(anilino)-2,6-diaryl-1,2,5,6-tetrahydropyridine-3-etyl carbonate compound and synthesis method thereof
06/09/2010CN101723879A Method for synthesizing (R)-3-ethyl piperidine hydrochloride
06/09/2010CN101723878A Preparation method of donepezil
06/09/2010CN101723877A Method for preparing piperidines compound by using pyridine base through catalytic hydrogenation
06/08/2010US7732615 dosage forms of pimavanserin tartrate, serotonin receptor antagonists, used for the treatment of psychological disorders
06/08/2010US7732463 such as 4-[2-(4-Chloro-phenylsulfanyl)-5-trifluoromethyl-phenyl]-piperidine, used as antidepressants and anxiolytic agents; treatment of panic and obsessive compulsive disorders
06/08/2010US7732462 Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
06/08/2010US7731787 Stabilization of triphenylboron-pyridine
06/08/2010CA2439241C Bipiperidinyl-derivatives and their use as chemokine receptors inhibitors
06/03/2010WO2010060852A1 Novel piperidine-butyramide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
06/03/2010US20100137605 Process for production of piperidine derivatives
06/03/2010US20100137603 Dialkylphenyl compounds having beta2 adrenergic receptor agonist and muscarinic receptor antagonist activity
06/03/2010US20100137600 Photogenerated reagents
06/03/2010US20100137401 2-methylprop anamides and their use as pharmaceuticals
06/03/2010US20100137368 Pyridine derivatives as fast dissociating dopamine 2 receptor antagonists
06/03/2010US20100137366 4- [2- (4-methylphenylsulfanyl) phenyl] piperidine for the treatment of irritable bowel syndrome (ibs)
06/03/2010US20100137365 Long chain N-alkyl compounds and oxa-derivatives thereof
06/03/2010US20100137334 Piperidine and Piperazine Derivatives
06/03/2010US20100137291 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use
06/03/2010US20100137229 Method Of Enhancing Lysosomal Alpha-Galactosidase A
06/03/2010US20100133519 Arylamine compounds and electronic devices
06/02/2010EP2190816A1 Non-peptidic promoters of apoptosis
06/02/2010EP1773772B1 New disubstituted phenylpiperidines/piperazines as modulators of dopamine neurotransmission
06/02/2010EP1562901B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/02/2010EP1553937B1 Glycinenitrile-based inhibitors of dipeptidyl peptidase iv
06/02/2010EP1326833B1 Substituted heterocyclic compounds for treating multidrug resistance
06/02/2010CN101720316A A new peptide deformylase inhibitor compound and manufacturing process thereof
06/02/2010CN101717363A Method for preparing roxatidine acetate hydrochloride
06/01/2010US7728145 Industrial method for separation and purification of fentanyl by reverse phase preparative chromatography
06/01/2010US7728144 Bronchodilators; treating chronic obstructive pulmonary disease or asthma; long duration of action; reduced side effects, such as dry-mouth and constipation; biphenyl carbamic acid, piperidinyl ester derivatives
1 ... 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 ... 380